Berenberg analyst Kerry Holford downgraded GlaxoSmithKline (GSK:LN) (NYSE: GSK) from Buy to Hold with a price target of INR16.00.The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE